“We believe a national RSV program is needed so all infants born in Australia have access to Beyfortus. A national program for next year’s RSV season will make it easier for parents and healthcare professionals to discuss infant eligibility, no matter where the child is born," said Regis Launay, the general manager of vaccines for Sanofi Australia and New Zealand. …
More states announce RSV programs as families call for national action
March 26, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Eight women named finalists for 2026 Marie Krogh Young Women in Science Prize
September 17, 2026 - - Latest News -
Your success makes you a target and take it as a compliment
September 16, 2026 - -
From constitutional promise to creaking system - the PBS at 80
September 16, 2026 - - Latest News -
Young Australians badly misjudge when fertility starts to decline, new survey finds
September 16, 2026 - - Latest News -
New research points to a 'Doctor gap' holding back clinical trial participation in Australia
September 16, 2026 - - Latest News -
New Zealand ranks last among wealthy nations on modern medicines access, new report finds
September 16, 2026 - - Latest News -
A shorter name and bolder blue for Novo in global rebrand
September 15, 2026 - - Latest News